DUSP5 and hemangioma: However, if inhibiting DUSP5 accelerates the disease in the first phase as the putative tumor suppressor role of DUSP5 would suggest, then, perhaps the involution second phase of hemangiomas could be triggered earlier assuming that the two phases are linked by a common mechanism involving DUSP5.